Boston biotech Celea Therapeutics raised $180 million from RA Capital, Leaps by Bayer and others to fund a Phase 3 trial of ...
Jamf Threat Labs has issued a report on new malware that users of the third-party clipboard manager Maccy need to be aware of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results